retatrutide trial update october 2025 This is exciting. 👀 The TRIUMPH-4 results for Lilly's investigational medication were released, showing weight loss of up to 71 lbs (~28%) over 68 weeks in the highest-dose group—far beyond Retatrutide Commercial Availability Timeline: Key

Pricing in the research market may actually decrease initially as the compound becomes more widely manufactured, but could also become more restricted as regulatory attention increases

PMID: 32163198

You dont have to be obese to try a GLP-1. Lose the last ten pounds. Get your summer body faster. Many videos feature women who are already thin explaining they only want to lose a few pounds

Many patients describe the constant intrusive thoughts about food food noise quieting within the first weeks

This shift isnt about chasing trends

Sustained elevation above the normal range carries theoretical concerns regarding cell proliferation, and tesamorelin is contraindicated in individuals with active malignancy